{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:31Z","timestamp":1790775751814,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2016.126","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T14:21:27Z","timestamp":1485526887000},"page":"e519-e519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["IFN-\u03b2 induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-\u03b1 in PBMCs of Adult T-cell Leukemia\/Lymphoma patients"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1969-7974","authenticated-orcid":false,"given":"T","family":"Dierckx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Decanine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Farre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Vandamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3234-8426","authenticated-orcid":false,"given":"J","family":"Van Weyenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"BFbcj2016126_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11912-013-0332-6","volume":"15","author":"A Mar\u00e7ais","year":"2013","unstructured":"Mar\u00e7ais A, Suarez F, Sibon D, Frenzel L, Hermine O, Bazarbachi A . Therapeutic options for adult T-cell leukemia\/lymphoma. Curr Oncol Rep 2013; 15: 457\u2013464.","journal-title":"Curr Oncol Rep"},{"key":"BFbcj2016126_CR2","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/84.15.1185","volume":"84","author":"TG Johns","year":"1992","unstructured":"Johns TG, Mackay IR, Callister KA, Hertzog PJ, Devenish RJ, Linnane AW . Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta. J Natl Cancer Inst 1992; 84: 1185\u20131190.","journal-title":"J Natl Cancer Inst"},{"key":"BFbcj2016126_CR3","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1128\/JVI.02564-08","volume":"83","author":"S Kinpara","year":"2009","unstructured":"Kinpara S, Hasegawa A, Utsunomiya A, Nishitsuji H, Furukawa H, Masuda T et al. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon. J Virol 2009; 83: 5101\u20135108.","journal-title":"J Virol"},{"key":"BFbcj2016126_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/ijc.2910510614","volume":"51","author":"T Oka","year":"1992","unstructured":"Oka T, Iwata J, Furihata M, Sonobe H, Miyoshi I, Ohtsuki Y . Inhibitory effects of human interferons on the immortalization of human, but not rabbit, T lymphocytes by human T-lymphotropic virus type-I (HTLV-I). Int J Cancer 1992; 51: 915\u2013920.","journal-title":"Int J Cancer"},{"key":"BFbcj2016126_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1743-422X-9-171","volume":"9","author":"B Moens","year":"2012","unstructured":"Moens B, Pannecouque C, L\u00f3pez G, Talledo M, Gotuzzo E, Khouri R et al. Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines. Virol J 2012; 9: 171.","journal-title":"Virol J"},{"key":"BFbcj2016126_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/sj.leu.2401742","volume":"14","author":"A Bazarbachi","year":"2000","unstructured":"Bazarbachi A, Nasr R, El-Sabban ME, Mah\u00e9 A, Mahieux R, Gessain A et al. Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia\/lymphoma. Leukemia 2000; 14: 716\u2013721.","journal-title":"Leukemia"},{"key":"BFbcj2016126_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1006\/viro.1999.9679","volume":"257","author":"D Smith","year":"1999","unstructured":"Smith D, Buckle GJ, Hafler DA, Frank DA, H\u00f6llsberg P . HTLV-I-infected T cells evade the antiproliferative action of IFN-\u03b2. Virology 1999; 257: 314\u2013321.","journal-title":"Virology"},{"key":"BFbcj2016126_CR8","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/1097-0142(19870315)59:6<1059::AID-CNCR2820590602>3.0.CO;2-M","volume":"59","author":"K Tamura","year":"1987","unstructured":"Tamura K, Makino S, Araki Y, Imamura T, Seita M . Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer 1987; 59: 1059\u20131062.","journal-title":"Cancer"},{"key":"BFbcj2016126_CR9","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"PS Gill","year":"1995","unstructured":"Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA et al. Treatment of adult t-cell leukemia\u2013lymphoma with a combination of interferon Alfa and Zidovudine. N Engl J Med 1995; 332: 1744\u20131748.","journal-title":"N Engl J Med"},{"key":"BFbcj2016126_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. a report from the lymphoma study group (1984-87). Br J Haematol 1991; 79: 428\u2013437.","journal-title":"Br J Haematol"},{"key":"BFbcj2016126_CR11","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/leu.2011.379","volume":"26","author":"S Nakahata","year":"2012","unstructured":"Nakahata S, Saito Y, Marutsuka K, Hidaka T, Maeda K, Hatakeyama K et al. Clinical significance of CADM1\/TSLC1\/IgSF4 expression in adult T-cell leukemia\/lymphoma. Leukemia 2012; 26: 1238\u20131246.","journal-title":"Leukemia"},{"key":"BFbcj2016126_CR12","doi-asserted-by":"publisher","first-page":"e1005560","DOI":"10.1371\/journal.ppat.1005560","volume":"12","author":"K Manivannan","year":"2016","unstructured":"Manivannan K, Rowan AG, Tanaka Y, Taylor GP, Bangham CRM . CADM1\/TSLC1 identifies HTLV-1-infected cells and determines their susceptibility to CTL-mediated lysis. PLOS Pathog 2016; 12: e1005560.","journal-title":"PLOS Pathog"},{"key":"BFbcj2016126_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3109\/10428191003728628","volume":"51","author":"Aa Alizadeh","year":"2010","unstructured":"Alizadeh Aa, Bohen SP, Lossos C, Martinez-Climent JA, Ramos JC, Cubedo-Gil E et al. Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha. Leuk Lymphoma 2010; 51: 1200\u20131216.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj2016126_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-10-52","volume":"10","author":"S Kinpara","year":"2013","unstructured":"Kinpara S, Kijiyama M, Takamori A, Hasegawa A, Sasada A, Masuda T et al. Interferon-\u03b1 (IFN-\u03b1) suppresses HTLV-1 gene expression and cell cycling, while IFN-\u03b1 combined with zidovudin induces p53 signaling and apoptosis in HTLV-1-infected cells. Retrovirology. Retrovirology;\\ 2013; 10: 1.","journal-title":"Retrovirology"},{"key":"BFbcj2016126_CR15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","volume":"108","author":"A Datta","year":"2006","unstructured":"Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, Canioni D et al. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 2006; 108: 1021\u20131029.","journal-title":"Blood"},{"key":"BFbcj2016126_CR16","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J et al. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet 2015; 47: 1304\u20131315.","journal-title":"Nat Genet"},{"key":"BFbcj2016126_CR17","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1038\/sj.onc.1203670","volume":"19","author":"J Sanc\u00e9au","year":"2000","unstructured":"Sanc\u00e9au J, Hiscott J, Delattre O, Wietzerbin J . IFN-\u03b2 induces serine phosphorylation of Stat-1 in Ewing\u2019s sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene 2000; 19: 3372\u20133383.","journal-title":"Oncogene"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj2016126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj2016126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj2016126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:21:51Z","timestamp":1671729711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj2016126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["BFbcj2016126"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2016.126","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]},"assertion":[{"value":"27 January 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}